Laryngeal papillomatosis future or investigational therapies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
[[Scientists]] and [[clinicians]] are working to discover more about laryngeal papillomatosis. While [[HPV|HPV 6]] and [[HPV|HPV 11]] are known causes, millions of people are exposed to these two [[virus]]es without developing the disease. It is not known why some people are more at risk than others or why some cases are much more serious than others. | [[Scientists]] and [[clinicians]] are working to discover more about laryngeal papillomatosis. While [[HPV|HPV 6]] and [[HPV|HPV 11]] are known causes, millions of people are exposed to these two [[virus]]es without developing the disease. It is not known why some people are more at risk than others or why some cases are much more serious than others. | ||
Researchers funded by the National Institute on [[Deafness]] and Other [[communication disorder|Communication Disorder]]s (NIDCD) are exploring how our [[gene]]s and [[immune system]] may contribute to our risk for contracting the disease as well as the severity of its [[symptom]]s. Researchers are also studying other possible [[therapy|therapies]] for laryngeal papillomatosis. In one [[clinical trial]], researchers are investigating whether a common [[anti-inflammatory drug]] can [[enzyme inhibitor|inhibit an enzyme]] that promotes [[tumor]] growth in laryngeal papillomatosis, thus reducing the recurrence of tumors in children and adults with laryngeal papillomatosis. Researchers are also investigating the effectiveness of a [[pulsed dye laser]], a [[laser]] that delivers short intense pulses of light, to determine if it is more effective at preserving the surrounding tissue while removing tumors from [[vocal fold]]s. In one NIDCD- sponsored clinical investigation, researchers are studying whether a certain [[dietary supplement]] can work with the [[pulsed dye laser]] to decrease the rate of recurrence of tumors in children with laryngeal papillomatosis. To read about these and other clinical trials, go to [http://www.clinicaltrials.gov/]. | Researchers funded by the National Institute on [[Deafness]] and Other [[communication disorder|Communication Disorder]]s (NIDCD) are exploring how our [[gene]]s and [[immune system]] may contribute to our risk for contracting the disease as well as the severity of its [[symptom]]s. Researchers are also studying other possible [[therapy|therapies]] for laryngeal papillomatosis. In one [[clinical trial]], researchers are investigating whether a common [[anti-inflammatory drug]] can [[enzyme inhibitor|inhibit an enzyme]] that promotes [[tumor]] growth in laryngeal papillomatosis, thus reducing the recurrence of tumors in children and adults with laryngeal papillomatosis. Researchers are also investigating the effectiveness of a [[pulsed dye laser]], a [[laser]] that delivers short intense pulses of light, to determine if it is more effective at preserving the surrounding tissue while removing tumors from [[vocal fold]]s. In one NIDCD- sponsored clinical investigation, researchers are studying whether a certain [[dietary supplement]] can work with the [[pulsed dye laser]] to decrease the rate of recurrence of tumors in children with laryngeal papillomatosis. To read about these and other clinical trials, go to [http://www.clinicaltrials.gov/ct2/show/NCT00550914?term=laryngeal+papillomatosis&rank=5 Pulsed Dye Laser for Juvenile Onset Recurrent Respiratory Papillomatosis]. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 16: | Line 16: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Diseases]] | |||
Revision as of 20:55, 26 December 2012
|
Laryngeal papillomatosis Microchapters |
|
Differentiating Laryngeal papillomatosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Laryngeal papillomatosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Laryngeal papillomatosis future or investigational therapies |
|
FDA on Laryngeal papillomatosis future or investigational therapies |
|
CDC on Laryngeal papillomatosis future or investigational therapies |
|
Laryngeal papillomatosis future or investigational therapies in the news |
|
Blogs on Laryngeal papillomatosis future or investigational therapies |
|
Risk calculators and risk factors for Laryngeal papillomatosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Scientists and clinicians are working to discover more about laryngeal papillomatosis. While HPV 6 and HPV 11 are known causes, millions of people are exposed to these two viruses without developing the disease. It is not known why some people are more at risk than others or why some cases are much more serious than others.
Researchers funded by the National Institute on Deafness and Other Communication Disorders (NIDCD) are exploring how our genes and immune system may contribute to our risk for contracting the disease as well as the severity of its symptoms. Researchers are also studying other possible therapies for laryngeal papillomatosis. In one clinical trial, researchers are investigating whether a common anti-inflammatory drug can inhibit an enzyme that promotes tumor growth in laryngeal papillomatosis, thus reducing the recurrence of tumors in children and adults with laryngeal papillomatosis. Researchers are also investigating the effectiveness of a pulsed dye laser, a laser that delivers short intense pulses of light, to determine if it is more effective at preserving the surrounding tissue while removing tumors from vocal folds. In one NIDCD- sponsored clinical investigation, researchers are studying whether a certain dietary supplement can work with the pulsed dye laser to decrease the rate of recurrence of tumors in children with laryngeal papillomatosis. To read about these and other clinical trials, go to Pulsed Dye Laser for Juvenile Onset Recurrent Respiratory Papillomatosis.